Literature DB >> 33712752

COVID antibody treatments show promise for preventing severe disease.

Heidi Ledford.   

Abstract

Entities:  

Keywords:  Immunology; SARS-CoV-2; Virology

Year:  2021        PMID： 33712752     DOI： 10.1038/d41586-021-00650-7

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  15 in total

1.  Bioluminescent and Fluorescent Reporter-Expressing Recombinant SARS-CoV-2.

Authors:  Desarey Morales Vasquez; Kevin Chiem; Chengjin Ye; Luis Martinez-Sobrido
Journal:  Methods Mol Biol       Date:  2022

Review 2.  A New Approach to the Management of COVID-19. Antagonists of IL-6: Siltuximab.

Authors:  Lucinda Villaescusa; Francisco Zaragozá; Irene Gayo-Abeleira; Cristina Zaragozá
Journal:  Adv Ther       Date:  2022-01-24       Impact factor: 3.845

3.  Probiotic improves symptomatic and viral clearance in Covid19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial.

Authors:  Pedro Gutiérrez-Castrellón; Tania Gandara-Martí; Ana T Abreu Y Abreu; Cesar D Nieto-Rufino; Eduardo López-Orduña; Irma Jiménez-Escobar; Carlos Jiménez-Gutiérrez; Gabriel López-Velazquez; Jordi Espadaler-Mazo
Journal:  Gut Microbes       Date:  2022 Jan-Dec

4.  Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles.

Authors:  Canhao Wu; Qin Xu; Huiyuan Wang; Bin Tu; Jiaxin Zeng; Pengfei Zhao; Mingjie Shi; Hong Qiu; Yongzhuo Huang
Journal:  Acta Pharm Sin B       Date:  2021-09-09       Impact factor: 14.903

5.  MG1141A as a Highly Potent Monoclonal Neutralizing Antibody Against SARS-CoV-2 Variants.

Authors:  Sua Lee; Shina Jang; Jihoon Kang; Soo Bin Park; Young Woo Han; Hyemi Nam; Munkyung Kim; Jeewon Lee; Ki Joon Cho; Jeonghun Kim; Miyoung Oh; Jihye Ryu; Jong Hyeon Seok; Yunhwa Kim; Jee-Boong Lee; Man-Seong Park; Yong-Sung Kim; Hosun Park; Dong-Sik Kim
Journal:  Front Immunol       Date:  2021-11-18       Impact factor: 8.786

6.  Real-time ultra-sensitive detection of SARS-CoV-2 by quasi-freestanding epitaxial graphene-based biosensor.

Authors:  Soaram Kim; Heeju Ryu; Sheldon Tai; Michael Pedowitz; John Robertson Rzasa; Daniel J Pennachio; Jenifer R Hajzus; Donald K Milton; Rachael Myers-Ward; Kevin M Daniels
Journal:  Biosens Bioelectron       Date:  2021-11-17       Impact factor: 10.618

7.  Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation.

Authors:  Claudia Cava; Gloria Bertoli; Isabella Castiglioni
Journal:  Future Virol       Date:  2021-07-20       Impact factor: 1.831

8.  Bamlanivimab use in mild-to-moderate COVID-19 disease: A matched cohort design.

Authors:  Christopher J Destache; Sarah J Aurit; David Schmidt; Laura Peet Erkes; Maureen Tierney; Renuga Vivekanandan
Journal:  Pharmacotherapy       Date:  2021-08-12       Impact factor: 6.251

9.  Personal observations on COVID-19 and the conduct and application of biomedical science.

Authors:  J C Smith; David W Goodhew
Journal:  Interface Focus       Date:  2021-10-12       Impact factor: 3.906

10.  Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients.

Authors:  Cristina Bergamaschi; Evangelos Terpos; Margherita Rosati; Matthew Angel; Jenifer Bear; Dimitris Stellas; Sevasti Karaliota; Filia Apostolakou; Tina Bagratuni; Dimitris Patseas; Sentiljana Gumeni; Ioannis P Trougakos; Meletios A Dimopoulos; Barbara K Felber; George N Pavlakis
Journal:  Cell Rep       Date:  2021-07-23       Impact factor: 9.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.